Triheptanoin Alleviates Ventricular Hypertrophy and Improves Myocardial Glucose Oxidation in Rats With Pressure Overload

Journal of Cardiac Failure

Volumn 21, Issue 11, 2015, Pages 906-915

  Nguyen, T Dung ^a   Shingu, Yasushige ^b   Amorim, Paulo A ^a   Schwarzer, Michael ^a   Doenst, Torsten ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

anaplerosis; cardiac hypertrophy; cardiac metabolism; Triheptanoin

Indexed keywords

GLUCOSE; INSULIN; KETONE BODY; TRIHEPTANOIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CITRIC ACID CYCLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ECHOCARDIOGRAPHY; FATTY ACID OXIDATION; GLUCOSE OXIDATION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART PERFUSION; HEART VENTRICLE HYPERTROPHY; INSULIN RESPONSE; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; CARDIAC MUSCLE; CONVALESCENCE; DISEASE MODEL; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECTS; ECHOGRAPHY; HEART CONTRACTION; HYPERTROPHY, LEFT VENTRICULAR; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; RANDOMIZATION; REFERENCE VALUE; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER; GLUCOSE; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXIDATION-REDUCTION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; REFERENCE VALUES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84946486888     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2015.07.009     Document Type: Article

References (32)

1. H.L. Kornberg The regulation of anaplerotic enzymes in E. coli Bull Soc Chim Biol (Paris) 49 1967 1479 1490
2. R.R. Russell 3rd, and H. Taegtmeyer Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate Am J Phys 261 1991 H1756 H1762
3. R.R. Russell 3rd, and H. Taegtmeyer Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate J Clin Invest 87 1991 384 390
4. C. des Rosiers, F. Labarthe, S.G. Lloyd, and J.C. Chatham Cardiac anaplerosis in health and disease: food for thought Cardiovasc Res 90 2011 210 219
5. N. Sorokina, J.M. O'Donnell, R.D. McKinney, K.M. Pound, G. Woldegiorgis, K.F. LaNoue, and et al. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts Circulation 115 2007 2033 2041
6. K.M. Pound, N. Sorokina, K. Ballal, D.A. Berkich, M. Fasano, K.F. Lanoue, and et al. Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy Circ Res 104 2009 805 812
7. S.C. Kolwicz Jr., D.P. Olson, L.C. Marney, L. Garcia-Menendez, R.E. Synovec, and R. Tian Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy Circ Res 111 2012 728 738
8. I.C. Okere, T.A. McElfresh, D.Z. Brunengraber, W. Martini, J.P. Sterk, H. Huang, and et al. Differential effects of heptanoate and hexanoate on myocardial citric acid cycle intermediates following ischemia-reperfusion J Appl Physiol (1985) 100 2006 76 82
9. F. Labarthe, R. Gelinas, and C. Des Rosiers Medium-chain fatty acids as metabolic therapy in cardiac disease Cardiovasc Drugs Ther 22 2008 97 106
10. C.R. Roe, and F. Mochel Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential J Inherit Metab Dis 29 2006 332 340
11. R.P. Kinman, T. Kasumov, K.A. Jobbins, K.R. Thomas, J.E. Adams, L.N. Brunengraber, and et al. Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats Am J Physiol Endocrinol Metab 291 2006 E860 E866
12. V. Zaha, J. Grohmann, H. Gobel, A. Geibel, F. Beyersdorf, and T. Doenst Experimental model for heart failure in rats-induction and diagnosis Thorac Cardiovasc Surg 51 2003 211 215
13. Y. Shingu, P. Amorim, T.D. Nguyen, F.W. Mohr, M. Schwarzer, and T. Doenst Myocardial performance (Tei) index is normal in diastolic and systolic heart failure induced by pressure overload in rats Eur J Echocardiogr 11 2010 829 833
14. T. Doenst, R.T. Richwine, M.S. Bray, G.W. Goodwin, O.H. Frazier, and H. Taegtmeyer Insulin improves functional and metabolic recovery of reperfused working rat heart Ann Thorac Surg 67 1999 1682 1688
15. T.D. Nguyen, Y. Shingu, P.A. Amorim, M. Schwarzer, and T. Doenst Glucagon-like peptide-1 reduces contractile function and fails to boost glucose utilization in normal hearts in the presence of fatty acids Int J Cardiol 168 2013 4085 4092
16. H. Taegtmeyer Switching metabolic genes to build a better heart Circulation 106 2002 2043 2045
17. J.R. Dyck, J.F. Cheng, W.C. Stanley, R. Barr, M.P. Chandler, S. Brown, and et al. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation Circ Res 94 2004 e78 e84
18. V. Lionetti, W.C. Stanley, and F.A. Recchia Modulating fatty acid oxidation in heart failure Cardiovasc Res 90 2011 202 209
19. N. Fillmore, and G.D. Lopaschuk Targeting mitochondrial oxidative metabolism as an approach to treat heart failure Biochim Biophys Acta 1833 2013 857 865
20. P.A. Amorim, T.D. Nguyen, Y. Shingu, M. Schwarzer, F.W. Mohr, A. Schrepper, and et al. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression J Thorac Cardiovasc Surg 140 2010 1160 1167
21. A. Chokshi, K. Drosatos, F.H. Cheema, R. Ji, T. Khawaja, S. Yu, and et al. Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure Circulation 125 2012 2844 2853
22. L. Zhang, J.S. Jaswal, J.R. Ussher, S. Sankaralingam, C. Wagg, M. Zaugg, and et al. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy Circ Heart Fail 6 2013 1039 1048
23. J. Mori, O.A. Alrob, C.S. Wagg, R.A. Harris, G.D. Lopaschuk, and G.Y. Oudit ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4 Am J Physiol Heart Circ Physiol 304 2013 H1103 H1113
24. W.Z. Martini, W.C. Stanley, H. Huang, C.D. Rosiers, C.L. Hoppel, and H. Brunengraber Quantitative assessment of anaplerosis from propionate in pig heart in vivo Am J Physiol Endocrinol Metab 284 2003 E351 E356
25. H.J. Atherton, M.S. Dodd, L.C. Heather, M.A. Schroeder, J.L. Griffin, G.K. Radda, and et al. Role of pyruvate dehydrogenase inhibition in the development of hypertrophy in the hyperthyroid rat heart: a combined magnetic resonance imaging and hyperpolarized magnetic resonance spectroscopy study Circulation 123 2011 2552 2561
26. L. Hue, and H. Taegtmeyer The Randle cycle revisited: a new head for an old hat Am J Physiol Endocrinol Metab 297 2009 E578 E591
27. F. Schuit, A. de Vos, S. Farfari, K. Moens, D. Pipeleers, T. Brun, and et al. Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells J Biol Chem 272 1997 18572 18579
28. T. Cheng, J. Sudderth, C. Yang, A.R. Mullen, E.S. Jin, J.M. Mates, and et al. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells Proc Natl Acad Sci U S A 108 2011 8674 8679
29. A.M. Katz, and B.H. Lorell Regulation of cardiac contraction and relaxation Circulation 102 2000 IV69 IV74
30. D.F. Dai, S.C. Johnson, J.J. Villarin, M.T. Chin, M. Nieves-Cintron, T. Chen, and et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure Circ Res 108 2011 837 846
31. D.F. Dai, T. Chen, H. Szeto, M. Nieves-Cintron, V. Kutyavin, L.F. Santana, and et al. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy J Am Coll Cardiol 58 2011 73 82
32. J.R. Ussher, J.S. Jaswal, and G.D. Lopaschuk Pyridine nucleotide regulation of cardiac intermediary metabolism Circ Res 111 2012 628 641